Literature DB >> 19411303

Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure.

Anne Bachelot1, Agnès Rouxel, Nathalie Massin, Jérome Dulon, Carine Courtillot, Christine Matuchansky, Yasmina Badachi, Anne Fortin, Bernard Paniel, Fabrice Lecuru, Marie-Aude Lefrère-Belda, Elisabeth Constancis, Elisabeth Thibault, Géri Meduri, Anne Guiochon-Mantel, Micheline Misrahi, Frédérique Kuttenn, Philippe Touraine.   

Abstract

OBJECTIVE: Premature ovarian failure (POF) encompasses a heterogeneous spectrum of conditions, with phenotypic variability among patients. The etiology of POF remains unknown in most cases. We performed a global phenotyping of POF women with the aim of better orienting attempts at an etiological diagnosis. DESIGN AND METHODS: We performed a mixed retrospective and prospective study of clinical, biological, histological, morphological, and genetic data relating to 357 consecutive POF patients between 1997 and 2008. The study was conducted at a reproductive endocrinology referral center.
RESULTS: Seventy-six percent of the patients presented with normal puberty and secondary amenorrhea. Family history was present in 14% of the patients, clinical and/or biological autoimmunity in 14.3%. Fifty-six women had a fluctuating form of POF. The presence of follicles was suggested at ultrasonography in 50% of the patients, and observed in 29% at histology; the negative predictive value of the presence of follicles at ultrasonography was 77%. Bone mineral density alterations were found in 58% of the women. Eight patients had X chromosomal abnormalities other than Turner's syndrome, eight other patients evidenced FMR1 pre-mutation. Two other patients had autoimmune polyendocrine syndrome type 2 and 1.
CONCLUSION: A genetic cause of POF was identified in 25 patients, i.e. 7% of the whole cohort. POF etiology remains most often undiscovered. Novel strategies of POF phenotyping are in such content mandatory to improve the rate of POF patients for whom etiology is identified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411303     DOI: 10.1530/EJE-09-0231

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  19 in total

Review 1.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

Review 2.  DSDs: genetics, underlying pathologies and psychosexual differentiation.

Authors:  Valerie A Arboleda; David E Sandberg; Eric Vilain
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

3.  Premature Ovarian Failure: An Association with Autoimmune Diseases.

Authors:  Vandana Jha; Deepti Goswami
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  Etiology of primary ovarian insufficiency in a series young girls presenting at a pediatric endocrinology center.

Authors:  Raja Brauner; Sophie Pierrepont; Joelle Bignon-Topalovic; Ken McElreavey; Anu Bashamboo
Journal:  Eur J Pediatr       Date:  2014-11-27       Impact factor: 3.183

Review 5.  Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.

Authors:  Jenny A Visser; Izaäk Schipper; Joop S E Laven; Axel P N Themmen
Journal:  Nat Rev Endocrinol       Date:  2012-01-10       Impact factor: 43.330

6.  Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement.

Authors:  Navira Samad; Hanh H Nguyen; Hikaru Hashimura; Julie Pasco; Mark Kotowicz; Boyd J Strauss; Peter R Ebeling; Frances Milat; Amanda J Vincent
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

7.  Mutant cohesin in premature ovarian failure.

Authors:  Sandrine Caburet; Valerie A Arboleda; Elena Llano; Paul A Overbeek; Jose Luis Barbero; Kazuhiro Oka; Wilbur Harrison; Daniel Vaiman; Ziva Ben-Neriah; Ignacio García-Tuñón; Marc Fellous; Alberto M Pendás; Reiner A Veitia; Eric Vilain
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

Review 8.  Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.

Authors:  Akimasa Takahashi; Abdelrahman Yousif; Linda Hong; IIana Chefetz
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

Review 9.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

10.  POI: Premature Ovarian Insufficiency/Pregnancy or Infertility?

Authors:  Ilaria Soave; Giuseppe Lo Monte; Roberto Marci
Journal:  N Am J Med Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.